12-125349497-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001366854.1(TMEM132B):c.113C>T(p.Ser38Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000818 in 1,613,694 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001366854.1 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TMEM132B | NM_001366854.1 | c.113C>T | p.Ser38Leu | missense_variant | 2/9 | ENST00000682704.1 | NP_001353783.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TMEM132B | ENST00000682704.1 | c.113C>T | p.Ser38Leu | missense_variant | 2/9 | NM_001366854.1 | ENSP00000507790.1 | |||
TMEM132B | ENST00000299308.7 | c.98C>T | p.Ser33Leu | missense_variant | 2/9 | 5 | ENSP00000299308.3 | |||
TMEM132B | ENST00000534945.2 | n.46C>T | non_coding_transcript_exon_variant | 1/4 | 5 | |||||
TMEM132B | ENST00000535330.1 | n.272C>T | non_coding_transcript_exon_variant | 3/3 | 4 |
Frequencies
GnomAD3 genomes AF: 0.000493 AC: 75AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000181 AC: 45AN: 248978Hom.: 0 AF XY: 0.000148 AC XY: 20AN XY: 135058
GnomAD4 exome AF: 0.0000390 AC: 57AN: 1461418Hom.: 0 Cov.: 34 AF XY: 0.0000344 AC XY: 25AN XY: 726986
GnomAD4 genome AF: 0.000493 AC: 75AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.000712 AC XY: 53AN XY: 74460
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 23, 2023 | The c.98C>T (p.S33L) alteration is located in exon 2 (coding exon 2) of the TMEM132B gene. This alteration results from a C to T substitution at nucleotide position 98, causing the serine (S) at amino acid position 33 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at